Search for: "Merck, Sharpe"
Results 241 - 260
of 266
Sorted by Relevance
|
Sort by Date
23 Dec 2020, 5:31 am
The AmeriKat has her mittens onin time for the cold, wintertradition of the AIPPI patentroundupA couple of weeks ago, instead of descending upon the hospitality of Hogan Lovells' London offices to devour patent law and mince pies, AIPPI UK members instead virtually attended the annual tradition that is the AIPPI UK Patent Cases Roundup. [read post]
29 Nov 2009, 3:13 pm
That’s a sharp departure from how the CBO treated similar mandates in the Clinton health plan. [read post]
11 Nov 2010, 12:54 pm
Merck & Co., 2003 WL 22902622, at *3 n.3 (E.D. [read post]
25 Jun 2018, 5:39 pm
Merck Sharp & Dohme Corp v. [read post]
24 Dec 2015, 8:20 am
In the original Hunger Games movie, while Katniss and Rue are plotting to blow up the Careers’ food stash, Katniss remarks that “destroying things is much easier than making them. [read post]
4 Feb 2024, 7:14 am
A noteworthy exception is the dispute between Merck Sharp & Dohme LLC (MSD) versus Spirig HealthCare AG (Spirig, a Stada subsidiary). [read post]
8 Aug 2018, 1:51 pm
The current Supreme Court is friendly toward big business. [read post]
30 Jun 2020, 9:36 am
In December 2012, Israeli generic player Teva decided to launch “at risk” in Italy its generic version of Montelukast, a leukotriene antagonist and a major respiratory medicine belonging to US based Merck Sharp & Dohme. [read post]
25 Jul 2023, 1:43 am
Merck Sharp & Dohme Corp). [read post]
15 Mar 2010, 3:18 pm
Does she think that Merck is paying me to speak about vaccines? [read post]
20 Mar 2009, 1:19 am
The 11-7 vote reflects sharp division over Johnsen's writings on abortion and national security. [read post]
6 Dec 2006, 6:45 pm
Both formulations are too broad and stand in sharp contrast to our admonitions in Embrex and Roche that the experimental use defense is very narrow and strictly limited. [read post]
30 Mar 2022, 4:31 am
Ltd [2022] FCAFC 39 (Ono) and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (MSD). [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
5 Aug 2010, 2:08 pm
When the Levine, Riegel, and Kent cases were briefed in the United States Supreme Court, we provided our readers with “users’ guides”/”guided tours” that summarized the defense side arguments and pointed out whatever we thought was interesting.Today we’re continuing that tradition with the Bruesewitz (sooner or later we’ll memorize how to spell that) v. [read post]
26 May 2011, 7:09 am
See Merck & Co., Inc. v. [read post]
25 May 2011, 11:46 pm
Therasense, now Abbott, got into a patent battle involving 5,820,551 and similar patents claiming "disposable blood glucose test strips for diabetes management. [read post]
30 Apr 2018, 2:31 pm
But Phillips and McCauley had a falling-out, and Phillips started posting allegations that McCauley was actually soft on the anti-vaccination movement and was actually "shillin for Merck"; part of his rhetoric was that anti-vaccination people had to save Ella from McCauley, who wasn't adequately protecting her from the evils of vaccines. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
